Frontiers in Clinical Drug Research - Anti Infectives- Vol 9

Author:

Frontiers in Clinical Drug Research - Anti Infectives- Vol 9

Volume 9

ISSN: 2452-3208
eISSN: 2352-3212 (Online)
ISBN: 978-981-5179-82-8
eISBN: 978-981-5179-81-1 (Online)

Introduction

Frontiers in Clinical Drug Research – Anti Infectives (Volume 9) is a book series that provides updated reviews on the latest advancements in development of pharmaceutical agents for treating infectious diseases. The series covers various topics, including chemistry, pharmacology, molecular biology, and biochemistry of natural and synthetic drugs. Additionally, it addresses multi-drug resistance and pre-clinical/clinical findings on antibiotics, vaccines, antifungal agents, and antitubercular drugs. This series is an invaluable resource for pharmaceutical scientists and postgraduate students, offering critical information to support clinical trials and research in anti-infective drug discovery and epidemiology.

The ninth volume presents five in-depth reviews, with topics including mature drugs and antivirals for COVID-19, bacteriocins as potent anti-infective agents, therapeutic interventions targeting free radicals in viral diseases, and a detailed exploration of natural anti-infective agents.

The five reviews included in this volume are:

  • - The role of mature drugs in the COVID-19 era
  • - Antivirals to treat COVID-19
  • - Ribosomally synthesized bacteriocins as potent anti-infective agents
  • - Therapeutic interventions against free radicals in viral diseases
  • - A comprehensive overview of natural anti-infective agents

Readership

Graduate students and researchers.

Contributors

Author(s):


Contributor(s):
Anamika Sharma
Pharmacology and Toxicology Lab
Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India


Christian Pasquali
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Daniel Zingg
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Giovanni A. Rossi
Pediatric Pulmonology and Allergy Unit
Istituto Giannina Gaslini
Genoa
Italy


Ghoson M. Daba
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Hermann Haller
Department of Nephrology and Hypertension
Hannover Medical School
Hannover
Germany


Marwa O. Elnahas
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Mayukh Hore
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Patil Shivprasad Suresh
Chemical Technology Division
CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India


Stefania Ballarini
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Sayan Bhattacharyya
All India Institute of Hygiene & Public Health
Kolkata
India


Subhrajyoti Roy
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Shubham Bhattacharyya
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Waill A. Elkhateeb
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Yogendra Padwad
Pharmacology and Toxicology Lab
Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India